Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface
Contact Lens and Anterior Eye · 2025
DOI: 10.1016/j.clae.2025.102475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Lens and Anterior Eye, 2025. Verfasst von Germán Mejía-Salgado und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias d…. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Matrix Metalloproteinase 9, Tears. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Universidad del Rosario.
Abstract (Originalsprache)
OBJECTIVE: The InflammaDry test detects matrix metalloproteinase-9 (MMP-9) in tears, a biomarker associated with ocular surface inflammation. While a positive result may indicate the need for anti-inflammatory therapy, its cost and qualitative nature limit widespread use. This study aims to identify clinical phenotypes that predict positive InflammaDry results, facilitating targeted anti-inflammatory therapy without requiring MMP-9 testing. METHODS: This retrospective study analyzed 1,363 patients with Dry Eye Disease (DED) from a dry eye clinic. Diagnosis was based on symptoms and at least one tear dysfunction sign. All patients underwent InflammaDry testing. Bivariate analysis (Chi-square, Student's t-test, Mann-Whitney-U) identified clinical factors associated with test positivity, which were further analyzed in a multivariable model. The proportion of InflammaDry-positive patients was compared across groups with increasing numbers of risk factors. RESULTS: The mean age of the population was 51.4 years; 84.1 % were female, and all were Hispanic. Multivariable analysis identified several significant predictors of positive InflammaDry results: the presence of any autoimmune or allergic disease (odds ratio, OR = 1.59), corneal staining (Oxford ≥3, OR = 2.41), conjunctival staining (Oxford ≥3, OR = 2.30), low tear film viscosity (OR = 1.55), and nasal (OR 1.80) or temporal (OR = 1.47) ocular redness (Jenvis score >2 by Oculus). The frequency of a positive InflammaDry increased from 69.9 % in the total population (n = 1,363) to 100 % in those with three identified risk factors (n = 9). CONCLUSION: Specific systemic and ocular phenotypes can predict InflammaDry test results. Patients with specific characteristics may not require MMP-9 testing due to the high likelihood of having a positive result, potentially leading to more targeted and cost-effective management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia; Ophthalmology I…
- Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia; Colombian Visua…
- Ophthalmology Interest Group Universidad del Rosario (OIG UR), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
- HORUS, Grupo Oftalmológico, Ltda, Bogotá, Colombia.
- Bascom Palmer Eye Institute, University of Miami, Surgical Services, Miami Veterans Administration, Miami, FL, USA.
- Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia. Electronic addr…
Förderung
- Universidad del Rosario
Zitieren
APA
Mejía-Salgado, G., Rojas-Carabali, W., Cifuentes-González, C., Diez-Bahamón, L. A., Kerguelén-Dumar, V., Téllez-Zambrano, J., García-Madero, J. J., Guevara-Carvajal, A., Moreno-Pardo, M. L., Tirado-Ángel, J., Marroquín-Gómez, G., Galor, A., & de-la-Torre, A. (2025). Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface. Contact Lens and Anterior Eye. https://doi.org/10.1016/j.clae.2025.102475
Vancouver
Mejía-Salgado G, Rojas-Carabali W, Cifuentes-González C, Diez-Bahamón LA, Kerguelén-Dumar V, Téllez-Zambrano J, et al. Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface. Contact Lens and Anterior Eye. 2025. doi:10.1016/j.clae.2025.102475
BibTeX
@article{MejaSalgado2025,
author = {Mejía-Salgado, Germán and Rojas-Carabali, William and Cifuentes-González, Carlos and Diez-Bahamón, Luis Alejandro and Kerguelén-Dumar, Valentina and Téllez-Zambrano, Juanita and García-Madero, Juan José and Guevara-Carvajal, Alejandro and Moreno-Pardo, Martha Lucía and Tirado-Ángel, Juliana and Marroquín-Gómez, Guillermo and Galor, Anat and de-la-Torre, Alejandra},
title = {Specific clinical phenotypes of dry eye disease can predict the presence of matrix metalloproteinase-9 in the ocular surface},
journal = {Contact Lens and Anterior Eye},
year = {2025},
doi = {10.1016/j.clae.2025.102475}
}
EUVIMED